feed,title,long_url,short_url
gNews,Esperion Therapeutics stock slumps 22% premarket as data from study of cholestrol-lowering drug fail to impress investors - MarketWatch,https://news.google.com/rss/articles/CBMiowFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vc3RvcnkvZXNwZXJpb24tdGhlcmFwZXV0aWNzLXN0b2NrLXNsdW1wcy0yMi1wcmVtYXJrZXQtYXMtZGF0YS1mcm9tLXN0dWR5LW9mLWNob2xlc3Ryb2wtbG93ZXJpbmctZHJ1Zy1mYWlsLXRvLWltcHJlc3MtaW52ZXN0b3JzLTYxNjE0MDBm0gGnAWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9hbXAvc3RvcnkvZXNwZXJpb24tdGhlcmFwZXV0aWNzLXN0b2NrLXNsdW1wcy0yMi1wcmVtYXJrZXQtYXMtZGF0YS1mcm9tLXN0dWR5LW9mLWNob2xlc3Ryb2wtbG93ZXJpbmctZHJ1Zy1mYWlsLXRvLWltcHJlc3MtaW52ZXN0b3JzLTYxNjE0MDBm?oc=5,https://da.gd/jCVF
